SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-028343
Filing Date
2024-07-18
Accepted
2024-07-18 16:30:28
Documents
18
Period of Report
2024-07-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40569
2 ex99-1.htm EX-99.1 29100
3 ex99-1_001.jpg GRAPHIC 4498
4 ex99-1_002.jpg GRAPHIC 51683
  Complete submission text file 0001493152-24-028343.txt   373049

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bctx-20240718.xsd EX-101.SCH 3750
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bctx-20240718_def.xml EX-101.DEF 26591
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bctx-20240718_lab.xml EX-101.LAB 36631
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bctx-20240718_pre.xml EX-101.PRE 25215
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5777
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-40101 | Film No.: 241125109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)